Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 25 Medical Angel Investors in France in November 2024

Last updated: Nov 2024 A list of 25 angel investors that invest in Medical startups based in France. We rank investors based on the number of investments they made in Medical companies from France. We update this investor list every month.

Top 25 Medical Angel Investors in France in November 2024

Investor	Medical France investments
Bernard Majoie	3
Nicolas Dessaigne	2
Pierre Kosciusko-Morizet	2
André-Jacques Auberton-Hervé	2
Daniel Caille	2
André-Jacques Auberton-Hervé	2
Guillaume Richard	2
Nicolas Douay	2
Bertrand Jelensperger	2
Bernard Chauvin	1
Victor Douce	1
Pierre Krings	1
Pierre Olivier Goineau	1
Charles-Edouard Bouee	1
Philippe du Mesnil	1
Geoffrey Duyk	1
Alain Tingaud	1
Flavien Kulawik	1
Dominique Vidal	1
Guillaume Amblard	1
Jean-Paul Kress	1
Rémi Gaston- Dreyfus	1
Olivier Occelli	1
Antoine Freysz	1
Giorgio Anania	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Bernard Majoie - President @ Fournier-Majoie

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Series A
France, Belgium

Portfolio highlights

reMYND — Driving the development of disease-modifying treatments
AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology

Nicolas is a firm believer of “culture-first” companies and am focused on building just that at Algolia where team empowerment is how they accomplish their goals. Prior to co-founding Algolia with Julien, he spent over 12 years working on information retrieval at Exalead and Thales.At Algolia they believe every website and app deserves greatsearch! they offer a hosted Search API that helps developers deliver an instant and relevant search experience. We’ve seen that search is a great touch point to optimize – they regularly see double digit increases in engagement on sites when they improve their search UX.When they founded Algolia in 2012 it was originally going to be a local SDK for mobile app search. They changed direction and realized that they needed to offer search as a hosted SaaS service, but it was those early mobile optimizations that gave us their unique advantage. They are one of the few search solutions that has been developed from scratch, and they never would have gone that direction if they hadn’t originally been focused on mobile search.His focus has been first and foremost on making Algolia a great place to work. They have a unique culture here that values ownership as its pillar. They want to create a company where every team member takes initiative, gets out of their comfort zone, is empowered to make decisions; in short: be free to be their best.He is recently spoken at SaaStock on the challenges of running a company based in both Paris and San Francisco. His priority lately has been on scaling their growth and ramping up their team size.

Investment focus

Software, Artificial Intelligence, SaaS
Pre-Seed, Seed, Series A
United States, France, Germany

Portfolio highlights

Arcjet — Arcjet helps developers protect their apps in just a few lines of code. Implement rate limiting, bot protection, email validation, and defense against common attacks.
Kestra Technologies — Use declarative language to build simpler, faster, scalable and flexible data pipelines
Yuma AI — Yuma is using ChatGPT to automate customer support. We integrate directly with help desk software and focus on helping large Shopify merchants deal with their high volume of support requests.

Pierre Kosciusko-Morizet is an Internet entrepreneur, founder and former CEO of French e-commerce pioneer PriceMinister. After he sold Priceminister to Japanese internet giant Rakuten in 2010 for $350m, he became Rakuten Europe COO. He left Rakuten in 2014 so as to concentrate on his investments and new project.Pierre Kosciusko-Morizet is agraduate of the famous HEC Paris business school, where he studied entrepreneurship. He launched his first company, Visualis SA (a consultancy for the distribution sector), while still studying at HEC, with a €10,000 student loan. After graduating from HEC, Kosciusko-Morizet moved to the United States and became a manager in the marketing department of Finance Capital One, an internet-based credit card company. There he managed a team of 60 analysts, and specialised in the online credit and banking market.It was there that Kosciusko-Morizet saw a gap in the market. While websites existed in the United States linking buyers and sellers online, there was no equivalent site in France. He resigned from Finance Capital One and returned to France two weeks later to work on what would become PriceMinister with Pierre Krings, Olivier Mathiot, Nathalie Maurin and Justin Ziegler. In 2001 Priceminister launched and has grown into one of the largest and most successful e-commerce companies in France, currently employing around 200 passionate and dedicated staff.Pierre Kosciusko-Morizet is a former President of the ACSEL (Association of the Digital Economy) and of the ASIC (Association of Internet Community Services), and Chairman and main investor of the Strategic Committee of ISAI, the “French internet entrepreneurs fund”, that raised over $100m. In 2010 Kosciusko-Morizet published an autobiographical book which details the story of PriceMinister.

Investment focus

Health Care, Internet, E-Commerce
Seed, Series A, Angel
France, Israel

Portfolio highlights

youzd — youzd is an e-commerce platform for second-hand furniture, electronics, and decoration products.
PowerZ — Tailored for kids ages 6 and up - learn Math, English, Geography, History, and Music in a universe that adapts to your level!
Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.

Dr. AndrÃ©-Jacques Auberton-HervÃ© co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-HervÃ© is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-HervÃ© managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 Âµm and 0.8 Âµm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-HervÃ© was elected to serve as the European representative to SEMIâ€™s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-HervÃ© is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cutâ„¢ technology and his overall contributions to the semiconductor industry as a whole. Auberton-HervÃ© is a member of the Electrochemical Society and the IEEE.

Investment focus

Medical, Biotechnology
Seed, Series A
France

Portfolio highlights

LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and

Daniel Caille

Investment focus

Elderly, Medical, Software
Series A, Pre-Seed, Funding Round
France

Portfolio highlights

HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Medylink —
CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.

Investment focus

Medical, Biotechnology
Seed, Series A
France

Portfolio highlights

LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and

Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.

Investment focus

Medical, Software, Health Care
Pre-Seed, Series A
France

Portfolio highlights

HypnoVR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.

Previously cofounder @ Keldoc - currently early stage investor @ Better Angle

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Pre-Seed, Angel
France, United Kingdom, Mauritius

Portfolio highlights

Bealy health — Bealy is a prevention and health solution dedicated to employees to improve their daily health and well-being.
Djamo — Djamo is a Provider of financial applications to allow customers to use their cards with zero fees in a wide range of services.
underdog — underdog is a simplified & refurbished household appliances.

Bertrand Jelensperger is the Co-Founder and Advisory Board at TheFork.

Investment focus

Apps, Organic Food, Software
Seed, Series A, Angel
France, Spain, Belgium

Portfolio highlights

Malou — Malou offers food marketing and digital marketing solutions for restaurants. The company also offers content management, restaurant marketing, reputation management, presence management, and SEO solutions.
Kiliba — 100% automated emailing platform: design of html templates in your colours, sending of personalised emails, marketing automation workflows, enriched CRM
Neptune Elements — Neptune Elements offerFrench seaweed of controlled origin, with exceptional taste and culture.

Bernard Chauvin, a renowned authority in the field of ophthalmology, sits on the company's Board of Directors.March 12, 2013 – EyeTechCare SA, has secured a third round of funding amounting to EUR 10 million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors which alsocontributed to this round of funding: the capital investment company Omnes Capital (formerly Crédit Agricole Private Equity) and the Lyon-based insurer SHAM. Bernard Chauvin is a physician specializing in ophthalmology. He headed the Laboratoires Chauvin for 27 years (until its acquisition by Bausch & Lomb), prior to joining Neurotech, a French biotechnology company where he served as Chief Executive Officer until 2004. Since then, he has taken an active role as a director in the development of a number of pharmaceutical and biotechnology companies.

Investment focus

Medical, Health Care, Medical Device
Series A, Series C
France

Portfolio highlights

EyeTechCare — EyeTechCare has developed a new medical device called EyeOP1. This leading edge technology device is the result of several years of joint research with INSERM which has led to the development of a treatment method using High Intensity Focused Ultrasound (HIFU).EyeOP1 is an ultrasound device which offers a non-invasive treatment for refractoryglaucoma. This new method is extremely accurate, simple and only takes one minute.
Ciliatech — Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects.

Victor Douce

Investment focus

Health Care, FinTech, Medical
Series C, Funding Round, Pre-Seed
United States, France, Germany

Portfolio highlights

Magnisense — Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires
The EVERY Company — Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.
Terran Biosciences — Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.

Pierre Krings is the founder of Price Minister.

Investment focus

Rental, Health Care, Information Technology
Funding Round, Seed, Series A
France

Portfolio highlights

Jam — Jam uses AI and process optimization to assist students in their daily lives.
Tracktor — Tracktor is a rental platform for construction workers, enabling them to rent out or borrow construction equipment in a few clicks.
Renovation Man — Renovation Man is a provider of services intended to revolutionize the world of renovation work.

Pierre Olivier Goineau - President @ Neuronax

Investment focus

Medical, Biopharma, Health Care
Funding Round
France

Portfolio highlights

Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.

Charles-Edouard Bouée is the CEO of Roland Berger. He is a seasoned expert in reorganization, post-merger projects and integration programs, as well as performance improvement, and specializes in disruptive innovation, new technologies and digital transformation.Charles-Edouard Bouée joined Roland Berger in 2001 as Senior Partner in the Parisoffice, where he headed the Financial Services and Energy & Utility Competence Centers. He became the Managing Partner of Roland Berger’s China office in 2006 and Head of the Asia Leadership Team in 2009.He then assumed responsibility for France, Belgium, Italy, Spain and Morocco. He has since fulfilled consulting mandates for leading international companies and organizations based in Europe, Asia and elsewhere. Charles-Edouard Bouée was appointed COO in July 2013 and elected CEO of Roland Berger in June 2014.Charles-Edouard Bouée has authored various books on modern management and China, as well as Artificial Intelligence.

Investment focus

AgTech, CleanTech, Financial Services
Pre-Seed, Seed, Angel
United States, France, Vietnam

Portfolio highlights

xRapid — xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobilesolution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea.
PaySika — PaySika is a financial technology startup developing mobile and web-based banking solutions for French-speaking African countries.
INTERSTELLAR LAB — autonomous modules for crop cultivation on Earth and life-support in Space

Philippe du Mesnil, a private investor

Investment focus

Medical, Manufacturing, Medical Device
Funding Round
France

Portfolio highlights

Ilasis — Ilasis is an innovative player in medical devices by applying frugal innovation to the challenges of ophthalmology. We designed Helix, a patented and unique laser solution, the first femtosecond laser of its kind, dedicated to capsulorhexis for cataract surgery

Dr. Geoffrey Duyk was a member of the Board from May 2006 through May 2011, and re-joined the Board in May 2012. Dr. Duyk is a partner of TPG Growth, LLC, an affiliate of TPG Biotechnology Partners II, L.P.Previously, he served on the board of directors and was President of Research and Development at Exelixis, Inc., a biopharmaceutical companyfocusing on drug discovery, from 1996 to 2003.Prior to Exelixis, Dr. Duyk was Vice President of Genomics and one of the founding scientific staff at Millennium Pharmaceuticals, from 1993 to 1996.Before that, Dr. Duyk was an Assistant Professor at Harvard Medical School in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute.Dr. Duyk currently serves on the boards of directors of several private companies and the non-profit Wesleyan University Board of Trustees. He served on the board of directors of Agria Corporation from August 2007 to May 2009, Cardiovascular Systems, Inc. (formerly Replidyne, Inc.) from 2004 to February 2009, Exelixis, Inc. from 1996 to 2003. Dr. Duyk holds a Bachelor of Arts degree in Biology from Wesleyan University and Doctor of Philosophy and Medicine degrees from Case Western Reserve University.

Investment focus

Biotechnology, Medical, Chemical
Series B, Series A, Series C
United States, Japan, France

Portfolio highlights

DNAnexus — The world's most secure & trusted biomedical cloud platform that accelerates clinical and scientific discovery with the potential to improve patient lives.
LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Aerie Pharmaceuticals — Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.

Alain Tingaud is a Founder & CEO at Alain Tingaud Innovations.

Investment focus

Software, E-Commerce, Cryptocurrency
Pre-Seed, Seed
France, Luxembourg

Portfolio highlights

Gonuggets — We help digitally native brands to grow their e-commerce revenue on marketplaces such as Amazon and D2C across EMEA.
MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
Trendex — Mobile App

Flavien Kulawik

Investment focus

Health Care, Artificial Intelligence, SaaS
Seed, Funding Round, Series A
France, United Kingdom

Portfolio highlights

Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Scienta Lab — Redefining precision immunology

Dominique Vidal is a Venture Partner at Index Ventures.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Seed
France, United States, United Kingdom

Portfolio highlights

Koyeb — Koyeb is a developer-friendly serverless platform to deploy apps globally. No-ops, servers, and infrastructure management.
Leavy.co — Leavy.co allows for anyone to live wherever they like, no matter how much they make, even for a day. Covid has turned our idea of work and travel upside down. It’s now all about mobility, for a generation who cannot afford it. The platform pays cash to all members willing to share their homes with the community or care for others.
Gens de Confiance — It is not enough to offer a wide range of products and services, you have to ensure that everyone is reliable. GensDeConfiance fights against online scams and build trust via a super-secured classifieds ad board. Our classifieds are only accessible to people who are endorsed by at least three other members. And if we have to remove someone, wealso remove all his referrers accounts! Therefore, not only we ensure that just the more reliable people can join, but every member is accountable at any time then.

Guillaume Amblard

Investment focus

Banking, Health Care, Environmental Consulting
Seed, Funding Round, Pre-Seed
France

Portfolio highlights

Keewe — Simply take part in the ecological transition thanks to your banking transactions and our exchange platform which acts in favour of the planet.
Cosmian — We offer a unique, comprehensive data protection suite powered by next-generation cryptography to secure your data in in use.
Scienta Lab — Redefining precision immunology

Jean-Paul Kress

Investment focus

Medical, Biotechnology
Seed
France

Portfolio highlights

LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and

Rémi Gaston- Dreyfus

Investment focus

Medical, Biotechnology
Seed
France

Portfolio highlights

LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and

Olivier started his career in 1998 as a Production and Quality Manager for DeliFrance, managing over 50 employees in three shifts, 7 days a week.In 2001, he became Sales Director for IMDS, a leading hosting and IT solutions provider in Western Europe. In 2007, Olivier founded NaturaBuy, a marketplace dedicated to outdoor sports, hunting andfishing, addressing a €2.5 billion market in France. NaturaBuy is now the leading marketplace of its sector, powering tens of thousands of transactions each month and €60 million in annual Transaction Volume.Olivier has backed some the most successful Kerala startups from their creation, such as Doctolib, Malt, admo.tv and Privateaser.Olivier holds a MSc in Engineering.Past and current Boards: Kerala Ventures, NaturaBuy (as CEO)

Investment focus

Medical, Hospital, Health Care
Seed
France

Portfolio highlights

Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.

After launching his first venture in 2000 (exited in 2002), Antoine joined the Travelocity / Lastminute group as Sales Director and then becoming COO. At that time, he directly managed 200 employees, including 50 salespeople.In 2009, he cofounded the “Startup Studio” Otium with Pierre-Edouard Sterin, Smartbox’s founder. Antoine built thefounding team, hiring Stanislas Niox-Château and Philippe de Chanville (5 years later, Stan will found Doctolib and Philippe ManoMano). As Otium CEO, Antoine conducted the acquisition of LaFourchette in 2009, led Lafourchette’s Board for 6 years (the startup grew from 3 to 250 salaries across 4 markets) and conducted the exit process to TripAdvisor in May 2014.Antoine cofounded a total of 6 “Otium” startups, among others Balinea, the leading platform for beauty institute bookings, and Weekendesk, an OTA for weekends generating above €100 million in Transaction Volume in 5 countries.Antoine graduated from HEC Paris.

Investment focus

SaaS, Video, Medical
Seed, Series A
France

Portfolio highlights

RockFi — RockFi is a private management company offering wealth management services.
Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
PlayPlay — Create professional videos and engage your audience with PlayPlay, the collaborative online video maker. No editing skills required. Try it free for 7 days.

Giorgio has spent more than 30 years in senior management at high-technology companies, from start-up ventures to international public companies, and has led two successful IPOs. He is chairman of Cube Optics AG and vice president of the executive board at Photonics21.Previously, Giorgio was CEO of Bookham, now Oclaro, which he grew from astart-up into a quarter-billion-dollar NASDAQ-listed public company. He also served as the vice president of sales, finance and business development for Flamel Technologies.Prior to that, he was the founder and general manager of the Miniplex DSL Business Unit at Raychem and strategy consultant at Booz Allen.He has a M.A. degree in physics from Oxford University and a Ph.D. in thermonuclear fusion from Princeton University.

Investment focus

Medical, Biotechnology
Seed
France

Portfolio highlights

LinKinVax — Covid-19 Vaccine Laboratory - Linkinvax - Leading the Revolution - The result of the association of French scientists and entrepreneurs, LinKinVax accelerates the development of safe, effective and scalable vaccines.

Investors by industry